Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.12 CAD | 0.00% | -14.29% | +20.00% |
Apr. 02 | Izotropic Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024 | CI |
Jan. 30 | Izotropic Corporation Receives Response from U.S. FDA | CI |
Sales 2022 | - | Sales 2023 | - | Capitalization | 17.89M 24.51M |
---|---|---|---|---|---|
Net income 2022 | -6M -8.22M | Net income 2023 | -5M -6.85M | EV / Sales 2022 | - |
Net Debt 2022 | 172K 235K | Net Debt 2023 | 1.97M 2.7M | EV / Sales 2023 | - |
P/E ratio 2022 |
-4.47
x | P/E ratio 2023 |
-3.05
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 89.73% |
1 week | -14.29% | ||
Current month | -7.69% | ||
3 months | -14.29% | ||
6 months | -14.29% | ||
Current year | +20.00% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 71 | 16-05-18 | |
Ralph Proceviat
DFI | Director of Finance/CFO | 73 | 19-11-17 |
Younes Achkire
COO | Chief Operating Officer | - | 21-06-29 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ralph Proceviat
DFI | Director of Finance/CFO | 73 | 19-11-17 |
Alexander Tokman
BRD | Director/Board Member | 62 | 22-11-10 |
Chief Executive Officer | 71 | 16-05-18 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-04 | 0.12 | 0.00% | 44,976 |
24-06-03 | 0.12 | -7.69% | 38,000 |
24-05-31 | 0.13 | 0.00% | 1,000 |
24-05-30 | 0.13 | -7.14% | 17,500 |
24-05-28 | 0.14 | +33.33% | 16,500 |
Delayed Quote Canadian Securities Exchange, June 04, 2024 at 12:27 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+20.00% | 4.82M | |
-11.17% | 13.77B | |
-14.97% | 2.4B | |
-45.53% | 2.39B | |
-18.85% | 1.35B | |
-.--% | 1.12B | |
+85.90% | 491M | |
+24.45% | 270M | |
-11.03% | 205M | |
+4.63% | 186M |
- Stock Market
- Equities
- IZO Stock